Patents by Inventor Sangeeta KUMARI

Sangeeta KUMARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ocular drug delivery
    Patent number: 11779543
    Abstract: This invention relates to a Nanostructured Lipid Carrier (NLC) particle comprising a therapeutic agent encapsulated therein for ocular delivery of the therapeutic agent, wherein the Nanostructured Lipid Carrier comprises: (i) a solid outer shell comprising a solid lipid, and (ii) a liquid core comprising a liquid lipid; and wherein the core comprises the therapeutic agent. Compositions of the NLC particles, use of the NLC particles, methods of treatment or prevention of an eye disorder and an eye drop dispenser are also provided.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: October 10, 2023
    Assignee: Waterford Institute of Technology
    Inventors: Gautam Behl, Sangeeta Kumari, Niall O'Reilly, Orla O'Donovan, Peter McLoughlin, David Kent, Laurence Fitzhenry, Elke Behaeghel
  • ARTIFICIAL TEARS
    Publication number: 20210386679
    Abstract: The invention relates to a Nanostructured Lipid Carrier (NLC) particle comprising: (i) a solid outer shell comprising a solid lipid, wherein the solid lipid comprises cholesterol; and (ii) a liquid core comprising a liquid lipid, wherein the liquid lipid comprises triglyceride; and related compositions, eye drop dispensers, uses and methods of treatment or prevention of a dry eye disorder in a subject.
    Type: Application
    Filed: November 5, 2019
    Publication date: December 16, 2021
    Inventors: Laurence FITZHENRY, Sangeeta KUMARI
  • MICROEMULSION FOR OPTHALMIC DRUG DELIVERY
    Publication number: 20210085603
    Abstract: This invention relates to a composition for ophthalmic delivery of a therapeutic agent, the composition comprising an oil-in-water (o/w) microemulsion comprising a fatty acid, or fatty acid ester, as the oil phase; an aqueous phase; a surfactant; and a co-surfactant, and wherein the composition further comprise a suspension of therapeutic agent-loaded nanoparticles. Use of the composition for the treatment or prevention of an eye disorder, a method of treatment or prevention of an eye disorder and an eye drop dispenser are also provided.
    Type: Application
    Filed: December 21, 2018
    Publication date: March 25, 2021
    Applicant: Waterford Institute of Technology
    Inventors: Gautam BEHL, Sangeeta KUMARI, Niall O'REILLY, Orla O'DONOVAN, Peter MCLOUGHLIN, David KENT, Laurence FITZHENRY
  • OCULAR DRUG DELIVERY
    Publication number: 20210085618
    Abstract: This invention relates to a Nanostructured Lipid Carrier (NLC) particle comprising a therapeutic agent encapsulated therein for ocular delivery of the therapeutic agent, wherein the Nanostructured Lipid Carrier comprises: (i) a solid outer shell comprising a solid lipid, and (ii) a liquid core comprising a liquid lipid; and wherein the core comprises the therapeutic agent. Compositions of the NLC particles, use of the NLC particles, methods of treatment or prevention of an eye disorder and an eye drop dispenser are also provided.
    Type: Application
    Filed: December 21, 2018
    Publication date: March 25, 2021
    Applicant: Waterford Institute Of Technology
    Inventors: Gautam BEHL, Sangeeta KUMARI, Niall O'REILLY, Orla O'DONOVAN, Peter MCLOUGHLIN, David KENT, Laurence FITZHENRY, Elke BEHAEGHEL